Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0.

摘要: Objectives: A consensus has been reached in The Netherlands that all future medical costs should be included economic evaluations. Furthermore, internationally, there is the recognition countries adopt a societal perspective estimates of nonmedical consumption are relevant for decision makers as much production gains are. aims of this paper are twofold: (1) to update tool Practical Application Include Future Disease Costs (PAID 1.1), based on 2013 data, the estimation unrelated and introduce costs, further standardizing and facilitating inclusion costs; (2) demonstrate how use practice, showing impact of including case-study where life hypothetically saved at different ages 2 additional cases published studies updated by including costs. Methods: Using latest cost illness data from year 2017, we model a function age, sex, time death, which varies per disease. Household Survey Centraal Bureau Statistiek is used estimate age. Results: incremental cost-effectiveness ratios (ICERs) case show can have substantial effect ICER, possibly affecting choices made makers. Conclusion: This article improves upon previous work provides first nonmedical consumption Netherlands.